The National Institutes of Health (NIH) is offering funding through the "Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS)" (R01 Clinical Trial Optional) grant. This initiative aims to support multidisciplinary research teams investigating biological mechanisms underlying HIV-associated comorbidities, co-infections, and complications that impact organs, tissues, or systems relevant to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The program encourages research focused on understanding pathobiology, pathophysiology, and metabolism to help prevent or alleviate HIV-related conditions within NIDDK’s scope.

Eligible applicants include a range of organizations, such as nonprofits, higher education institutions, state and local governments, tribal governments, small businesses, and certain foreign entities. Faith-based, community-based organizations, and minority-serving institutions are also eligible. The award ceiling is set at $500,000, though the total funding amount for the program has not been specified.

Applications must be submitted by December 10, 2024. Researchers are encouraged to review the full guidelines on the NIH website for application specifics and eligibility requirements. For additional information or assistance, applicants can contact NIH Grants Information.